Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05792137 · ClinicalTrials.gov registry record · NA

Postprandial Monocyte Study

A NA study, sponsored by USDA, Western Human Nutrition Research Center.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT05792137: Completed NA study, sponsored by USDA, Western Human Nutrition Research Center.

NCT05792137 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05792137, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The purpose of this research is to determine the role of a type of immune cell in blood, called a non-classical monocytes (NCMs), following consumption of a high-fat meal. Previous studies have found that monocytes are important for blood vessel health. In this study, two different high-fat meals will be used to study the effect of different types of dietary fat on postprandial NCMs. The investigators will characterize NCMs in both fasting conditions and following consumption of two different high-fat meals, and will evaluate whether the type of fat in a meal affects NCMs in blood.

Primary Outcome

Monocyte subsets will be analyzed using flow cytometry. Subset analysis will be performed by labeling immune cells with anti-cluster of differentiation antigen 45 (anti-CD45), cluster of differentiation antigen 91 (anti-CD91), anti-CD14, and anti-CD16 fluorescently labeled antibodies.

Interventions

  • OTHER High saturated fat challenge meal
  • OTHER High mono unsaturated fat challenge meal

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2023-11-14
Est. Completion 2024-10-11
Phase NA

What the finished NCT05792137 record still lists

NCT05792137 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which High saturated fat challenge meal is the first listed.

NCT05792137 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05792137 about?

NCT05792137 is a clinical study titled "Postprandial Monocyte Study". The purpose of this research is to determine the role of a type of immune cell in blood, called a non-classical monocytes (NCMs), following consumption of a high-fat meal. Previous studies have found that monocytes are important for blood vessel health. In this study, two different high-fat meals wi...

What is the current status of trial NCT05792137?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-11-14. Estimated completion is 2024-10-11.

What interventions are being tested in trial NCT05792137?

The interventions under investigation include: High saturated fat challenge meal (OTHER), High mono unsaturated fat challenge meal (OTHER).

Who is sponsoring clinical trial NCT05792137?

This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05792137's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05792137, the US trial registry maintained by the National Library of Medicine. NCT05792137 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.